SGMO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sangamo Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.1798 USD 61.4% Market Closed

Market Cap: $29.5m

	Sangamo Therapeutics Inc OTC:SGMO	US
F	FARO Technologies Inc SWB:FT1	US
	Quinsam Capital Corp F:0Q4	CA
A	Aptevo Therapeutics Inc F:AP8N	US
	SecMark Consultancy Ltd NSE:SECMARK	IN
J	Jade Leader Corp OTC:MCKRF	CA
B	Braskem SA BOVESPA:BRKM6	BR
L	Lion One Metals Ltd XMUN:LY1	CA
A	Aqaseem Factory for Chemicals and Plastics Co SAU:9539	SA

Profitability Summary

Sangamo Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-358%

Negative 3Y Average Operating Margin

-449%

Declining Operating Margin

-46% > -358%

Negative Net Margin

-357%

Negative 3Y Average Net Margin

-559%

Declining Net Margin

-91% > -357%

Negative Free Cash Flow Margin

-262%

Negative 3Y Average Free Cash Flow Margin

-366%

Declining Free Cash Flow Margin

-121% > -262%

Exceptional ROE

1 756%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-211%

Declining ROIC

-43% > -440%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.